IL312688A - Methods and compositions for treating conditions associated with central hypoventilation - Google Patents
Methods and compositions for treating conditions associated with central hypoventilationInfo
- Publication number
- IL312688A IL312688A IL312688A IL31268824A IL312688A IL 312688 A IL312688 A IL 312688A IL 312688 A IL312688 A IL 312688A IL 31268824 A IL31268824 A IL 31268824A IL 312688 A IL312688 A IL 312688A
- Authority
- IL
- Israel
- Prior art keywords
- preparations
- treatment
- methods
- conditions related
- central hypoventilation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278324P | 2021-11-11 | 2021-11-11 | |
| US202263305305P | 2022-02-01 | 2022-02-01 | |
| PCT/US2022/049483 WO2023086433A1 (en) | 2021-11-11 | 2022-11-10 | Methods and compositions for treating conditions associated with central hypoventilation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL312688A true IL312688A (en) | 2024-07-01 |
Family
ID=84627454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312688A IL312688A (en) | 2021-11-11 | 2022-11-10 | Methods and compositions for treating conditions associated with central hypoventilation |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250000823A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4429649A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024541315A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240108453A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022387440A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237151A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312688A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005600A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023086433A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207125A1 (en) * | 2024-03-26 | 2025-10-02 | The Regents Of The University Of California | Combination pharmacological interventions for obstructive sleep apnea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP3685858A1 (en) * | 2019-01-24 | 2020-07-29 | Assistance Publique-Hopitaux De Paris | A noradrenergic system stimulator in the treatment of central hypoventilation syndromes |
| US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
-
2022
- 2022-11-10 MX MX2024005600A patent/MX2024005600A/es unknown
- 2022-11-10 US US18/709,055 patent/US20250000823A1/en active Pending
- 2022-11-10 KR KR1020247019140A patent/KR20240108453A/ko active Pending
- 2022-11-10 EP EP22830640.3A patent/EP4429649A1/en active Pending
- 2022-11-10 IL IL312688A patent/IL312688A/en unknown
- 2022-11-10 AU AU2022387440A patent/AU2022387440A1/en active Pending
- 2022-11-10 JP JP2024527312A patent/JP2024541315A/ja active Pending
- 2022-11-10 WO PCT/US2022/049483 patent/WO2023086433A1/en not_active Ceased
- 2022-11-10 CA CA3237151A patent/CA3237151A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250000823A1 (en) | 2025-01-02 |
| EP4429649A1 (en) | 2024-09-18 |
| WO2023086433A1 (en) | 2023-05-19 |
| MX2024005600A (es) | 2024-05-21 |
| KR20240108453A (ko) | 2024-07-09 |
| JP2024541315A (ja) | 2024-11-08 |
| CA3237151A1 (en) | 2023-05-19 |
| AU2022387440A1 (en) | 2024-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285269A (en) | Compositions and methods for treating neurocognitive disorders | |
| IL285270A (en) | Compositions and methods for treating neurocognitive disorders | |
| IL287456A (en) | Cannabinoid compositions and methods of using | |
| IL288909A (en) | Methods of making bempedoic acid and compositions of the same | |
| PL3858333T3 (pl) | Wytwarzanie i przechowywanie liposomalnych preparatów rna odpowiednich do terapii | |
| IL281726A (en) | Manufacture of compounds and compositions for inhibiting the activity of shp2 | |
| EP4089115A4 (en) | Anti-tigit antibodies and usage method | |
| IL281082A (en) | Compositions of cxcr4 inhibitors and methods of preparation and use | |
| IL270894A (en) | Human antibodies to bet v 1 and methods of use thereof | |
| HRP20260212T1 (hr) | Pripravci i postupci za liječenje mišićne distrofije | |
| PL3761980T3 (pl) | Związki aminokwasowe i sposoby zastosowania | |
| IL272253A (en) | Compositions and methods for treatment of inflammatory conditions and diseases of the skin | |
| IL287796A (en) | Compositions and methods for the treatment of atpase-mediated diseases | |
| IL289970A (en) | Compositions and methods for treating autoimmune disorders | |
| EP3826667A4 (en) | CLAUDIN6 ANTIBODIES AND METHODS OF TREATMENT OF CANCER | |
| IL269158A (en) | Compositions and methods for treating inflammatory diseases | |
| IL284414A (en) | Methods and compositions for the treatment of fabry disease | |
| IL280330A (en) | Compositions and related methods for agriculture | |
| IL286492A (en) | Sialidase-resistant saccharide and method of making and using the same | |
| IL280807A (en) | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | |
| IL312121A (en) | T cell manufacturing compositions and methods | |
| IL283136A (en) | Antibodies to mucin-16 and methods of use thereof | |
| IL290891A (en) | Compositions and methods of treating vascular diseases | |
| EP4065161A4 (en) | HIGH CONCENTRATION FORMULATIONS OF ANTI-CSF1 AND ANTI-CSF1R ANTIBODIES | |
| IL289171A (en) | Anti-cd53 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof |